Health Reversion Effects of Autoprobiotics on Serum and Urine Metabolomes in Patients With Metabolic Syndrome: A Pilot Study
Molecular Nutrition & Food Research · 2026-01 · 70 (1)
DOI: 10.1002/mnfr.70273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 10.11.2025. Verfasst von Elena Ermolenko und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Medicine, St. Petersburg, Russia. Hauptthemen laut MEDLINE: Metabolic Syndrome, Metabolome, Probiotics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
The effectiveness of oral administration of autoprobiotic (nonpathogenic, indigenous) Enterococcus faecium or Enterococcus hirae for 20 days in patients with metabolic syndrome (MetS), characterized by obesity and impaired carbohydrate and lipid metabolism, was investigated. The dynamics of changes in anthropometric, biochemical parameters, and metabolism were monitored 14 and 28 days after the end of therapy. Clinical and laboratory changes after using autoprobiotics indicate a decrease in the severity of MetS. In the reversed‐phase high‐performance liquid chromatography–mass spectrometry analysis of blood serum metabolome, a significant decrease in the levels of all identified long‐chain acylcarnitines – palmitoyl‐L‐carnitine (C16:0), stearoyl‐L‐carnitine (C18:0), and oleoyl‐L‐carnitine (C25), trimethylamine‐N‐oxide, and homocysteine 14 and 28 days after the end of therapy, and, conversely, a significant increase in L‐histidine levels. The targeted gas–liquid chromatography showed an increase in the concentrations of hippuric, glycolic, methylmalonic acids, and 5‐oxoproline at the same time. The effectiveness of therapy is confirmed by changes in serum and urinary metabolism, primarily aimed at correcting these and reducing signs characteristic of patients with obesity and impaired energy metabolism. The revealed positive changes in the concentration of individual serum and urine metabolites allow for their further use in a targeted study to predict the severity of MetS and the effectiveness of its therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental Medicine, St. Petersburg, Russia.
- Functional Metabolomics and Human Microbiome Research Group, Institute of Perinatology and Pediatrics, Almazov National Medical Research Centre, St. Petersburg, Russia.
- Department of Internal Diseases, Gastroenterology and Dietetics, North-Western State Medical University Named After I.I. Mechnikov, St. Petersburg, Russia.
- Research Institute of Hygiene, Occupational Pathology and Human Ecology, FMBA, St. Petersburg, Russia.
ORCID-Profile: Elena Ermolenko
Zitieren
APA
Ermolenko, E., Sitkin, S., Alferova, L., Ilyushonok, S., Beltyukov, P., Babakov, V., Novikova, N., Gladyshev, N., Berdichevskiy, G., Demchenko, E., & Suvorov, A. (2026). Health Reversion Effects of Autoprobiotics on Serum and Urine Metabolomes in Patients With Metabolic Syndrome: A Pilot Study. Molecular Nutrition & Food Research, 70(1). https://doi.org/10.1002/mnfr.70273
Vancouver
Ermolenko E, Sitkin S, Alferova L, Ilyushonok S, Beltyukov P, Babakov V, et al. Health Reversion Effects of Autoprobiotics on Serum and Urine Metabolomes in Patients With Metabolic Syndrome: A Pilot Study. Molecular Nutrition & Food Research. 2026;70(1). doi:10.1002/mnfr.70273
BibTeX
@article{Ermolenko2026,
author = {Ermolenko, Elena and Sitkin, Stanislav and Alferova, Lyubov and Ilyushonok, Semyon and Beltyukov, Petr and Babakov, Vladimir and Novikova, Nadezhda and Gladyshev, Nikita and Berdichevskiy, Grigoriy and Demchenko, Elena and Suvorov, Alexander},
title = {Health Reversion Effects of Autoprobiotics on Serum and Urine Metabolomes in Patients With Metabolic Syndrome: A Pilot Study},
journal = {Molecular Nutrition & Food Research},
year = {2026},
volume = {70},
number = {1},
doi = {10.1002/mnfr.70273}
}
EUVIMED